TRIPLE G WEIGHT LOSS 10MG RETA GREAT RESULTS! !!!PREORDER!!! *1 WEEK WAITING*

TRIPLE G 10 mg VIAL – Retatrutide

TRIPLE G 10 mg Vial (Retatrutide) is a high-purity peptide formulation designed to support metabolic balance, body composition goals, and overall metabolic efficiency. By acting on three key metabolic pathways — GLP-1, GIP, and glucagon receptors — retatrutide offers a synergistic approach to appetite regulation, glucose balance, and fat metabolism.

This product is supplied in vial form and contains 10 mg of retatrutide in lyophilised format, allowing flexible preparation according to individual protocols.

Key Features of TRIPLE G 10 mg Vial

Triple-Receptor Metabolic Support

Retatrutide is known for its unique triple-action mechanism:

• GLP-1 receptor activity – supports appetite control, satiety, and glucose stability

• GIP receptor activity – supports insulin sensitivity and fat metabolism

• Glucagon receptor activity – supports metabolic rate and energy utilisation

The combined action of these pathways provides broader metabolic support compared to single-pathway solutions.

Vial Format & Preparation

• Supplied as a 10 mg vial

• Vial is unlabelled

• Product requires reconstitution with sterile saline solution prior to use

• Allows precise and flexible preparation depending on individual needs

Metabolic & Body Composition Support

Appetite & Weight Management

Activation of GLP-1 and GIP pathways supports satiety and appetite control, which may contribute to reduced caloric intake. Glucagon receptor activity supports fat metabolism and energy use.

Glucose & Insulin Support

The GLP-1 and GIP mechanisms help support balanced glucose levels and improved insulin responsiveness, making this product relevant for metabolic optimisation.

Overall Metabolic Function

By supporting multiple metabolic pathways, TRIPLE G 10 mg Vial contributes to long-term metabolic efficiency and energy balance.

Suggested Starting Protocol

A common starting amount is 1–2 mg once weekly, with adjustments made gradually based on individual response and goals.

Tolerability & Safety Information

Possible Reactions

Most users tolerate retatrutide well. Some may experience mild and temporary effects such as:

• Nausea

• Digestive discomfort

• Light dizziness

These effects often resolve as the body adapts.

Not Recommended For

• Individuals sensitive to any component of the product

• Those with severe liver or kidney impairment

• Individuals with active oncological conditions

Consultation with a qualified healthcare professional is advised before use.